En Face Optical Coherence Tomography Imaging of Foveal Dots in Eyes With Posterior Vitreous Detachment or Internal Limiting Membrane Peeling.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
02 08 2021
Historique:
entrez: 5 8 2021
pubmed: 6 8 2021
medline: 28 9 2021
Statut: ppublish

Résumé

To analyze the morphology of foveal hyperreflective dots (HRD) identified with en face optical coherence tomography (OCT) and evaluate the effects of internal limiting membrane (ILM) peeling and posterior vitreous detachment (PVD) on the number of these lesions. Retrospective cross-sectional study of patients with OCT angiography and en face OCT. Using en face OCT, superficial HRD lying on the foveal floor were measured and quantitated in eyes with ILM peel and in the fellow nonsurgical eyes. Eyes with foveal PVD were also compared to fellow eyes without foveal PVD. High-magnification en face OCT was also performed to better understand the morphology of HRD in the fovea. Eyes that underwent ILM peel (n = 10) displayed fewer HRD (P = 0.012) compared to control fellow nonoperated eyes. In eyes with foveal PVD, the mean number of HRD was numerically greater, but without statistical significance, compared to the contralateral eye without foveal PVD. High-magnification en face OCT illustrated HRD with irregular shapes and fine cilia-like or dendriform extensions. Average length of HRD was between 15 to 21 µm in all four groups. HRD decreased in eyes with ILM peeling by en face OCT compared with fellow nonoperated eyes and exhibited a glial cell-like morphology and size closely resembling the white dot fovea described previously using scanning electron microscopy. HRD may represent processes of activated retinal glia, possibly Muller cells, that traverse defects in the ILM.

Identifiants

pubmed: 34351357
pii: 2776551
doi: 10.1167/iovs.62.10.5
pmc: PMC8354030
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5

Références

Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4451-4461
pubmed: 31652329
Arch Ophthalmol. 1991 Jul;109(7):966-71
pubmed: 2064577
Invest Ophthalmol Vis Sci. 2011 Oct 03;52(11):7822-34
pubmed: 21900375
Graefes Arch Clin Exp Ophthalmol. 1986;224(2):124-30
pubmed: 3949186
Ophthalmol Retina. 2019 Feb;3(2):122-132
pubmed: 31014759
Am J Ophthalmol. 1997 Jan;123(1):76-83
pubmed: 9186100
Ophthalmology. 2018 Feb;125(2):227-236
pubmed: 28867131
Ophthalmol Retina. 2020 Nov;4(11):1093-1102
pubmed: 32442535
Arch Ophthalmol. 1998 Jan;116(1):110-1
pubmed: 9445222
Am J Ophthalmol. 2018 Apr;188:29-40
pubmed: 29360459
Exp Eye Res. 2018 Feb;167:110-117
pubmed: 29242027
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT1-OCT13
pubmed: 27409459
Arch Ophthalmol. 2012 Dec;130(12):1603-5
pubmed: 23229705
Retina. 2014 Jul;34(7):1360-6
pubmed: 24667569
Exp Eye Res. 2016 Sep;150:44-61
pubmed: 26220834
Am J Ophthalmol. 2010 Mar;149(3):371-82.e1
pubmed: 20172065
Ophthalmol Retina. 2020 Feb;4(2):148-153
pubmed: 31864940
Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):1887-94
pubmed: 25377434
Am J Ophthalmol. 2019 Mar;199:71-81
pubmed: 30448463
Invest Ophthalmol Vis Sci. 1977 May;16(5):416-22
pubmed: 852943
Biomed Hub. 2020 Jun 12;5(2):79-86
pubmed: 32775337
Am J Ophthalmol. 2017 May;177:131-138
pubmed: 28237415
Am J Ophthalmol. 2021 Mar 24;229:108-119
pubmed: 33773982
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977 Dec 31;204(4):223-34
pubmed: 304681
Arch Ophthalmol. 1999 Jun;117(6):744-51
pubmed: 10369584
Retina. 2019 May;39(5):972-979
pubmed: 29474307
Ophthalmology. 2014 Dec;121(12):2489-500
pubmed: 25282252
Retina. 2019 Feb;39(2):339-346
pubmed: 29232330
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Invest Ophthalmol Vis Sci. 2011 Mar 18;52(3):1486-92
pubmed: 21071737
Retina. 2016 Jul;36(7):1408-12
pubmed: 27164549

Auteurs

Cameron Pole (C)

Retinal Disorders and Ophthalmic Genetics, Stein Eye Institute, University of California at Los Angeles, Los Angeles, California, United States.

Adrian Au (A)

Retinal Disorders and Ophthalmic Genetics, Stein Eye Institute, University of California at Los Angeles, Los Angeles, California, United States.

Eduardo Navajas (E)

Department of Ophthalmology and Visual Sciences, Eye Care Center, University of British Columbia, British Columbia, Vancouver, Canada.

K Bailey Freund (KB)

Vitreous Retina Macula Consultants of New York, New York, New York, United States.
Department of Ophthalmology, New York University Grossman School of Medicine, New York, New York, United States.

Srinivas Sadda (S)

Doheny Eye Institute, Los Angeles, California, United States.
University of California at Los Angeles, Los Angeles, California, United States.

David Sarraf (D)

Retinal Disorders and Ophthalmic Genetics, Stein Eye Institute, University of California at Los Angeles, Los Angeles, California, United States.
Greater Los Angeles VA Healthcare Center, Los Angeles, California, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH